Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gadovist (gadobutrol) contrast-enhanced breast MRI in newly diagnosed breast cancer
2009-009597-27Phase 3Completed
- Sponsor
- Bayer
- Start
- Dec 2009
- Modality
- Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of gadobutrol in breast cancer, sponsored by Bayer. Primary endpoint: Primary diagnostic efficacy endpoint. Started Dec 2009; status: completed.
02
Drugs
gadobutrol
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2009-009597-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-009597-27.